Feed

Amphastar Pharmaceuticals Teva Pharmaceutical Industries Viatris

Trump Proposes Tariffs on Imported Generic Medicines, Raising Concerns Over Production and Pricing

President Trump's proposed tariffs on imported generic medicines could significantly impact the pharmaceutical industry, particularly affecting low-cost drug manufacturers' ability to compete and maintain pricing structures. The tariffs, which could reach as high as 200%, raise concerns about the future of generic drug production and pricing in the U.S.